Učitavanje...
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
Integrase inhibitors represent an important new class of antiretroviral drugs. Elvitegravir, the second available integrase inhibitor to be submitted for regulatory approval appears to be a promising once-daily agent when combined with other antiretroviral drugs. Elvitegravir has demonstrated good e...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3280623/ https://ncbi.nlm.nih.gov/pubmed/22347806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S20993 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|